METHYL 3-[4-(2-HYDROXY-3-PROPAN-2-YLAMINO-PROPOXY)PHENYL]PROPANOATE HYDROCHLORIDE | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Minakem Esmolol Hydrochloride

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 10 USDMF, 4 EU WC, 4 NDC API, 10 Listed Suppliers, $ API Reference Price

15 API Suppliers
10 USDMF
4 EU WC
4 NDC API
10 Listed Suppliers
$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 25 FDA Orange Book, 9 Europe, 2 Canada, 1 South Africa, 5 Listed Dossiers

42 FDF Dossiers
25 FDA Orange Book
9 Europe
2 Canada
1 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 10MG/ML, INJECTABLE;INJECTION - 1GM/100ML, INJECTABLE;INJECTION - 2GM/100ML

INJECTABLE;INJECTION - 10MG/ML
INJECTABLE;INJECTION - 1GM/100ML
INJECTABLE;INJECTION - 2GM/100ML

RELATED EXCIPIENT COMPANIES

3 Actylis

3 Actylis

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

1 Data Compilation #PharmaFlow
13 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Regulatory FDF Prices

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 7 Health Canada Patents

4 US Patents
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

1 USP
3 Others

$ API Ref.Price (USD/KG) : 2,930 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4HQ SPCLT PHARMA

filter Patent Number Reset all filters

4 All

01 28829054

02 28835505

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42033-03-15

Zhejiang Esmolol Hydrochloride

Product Main Page

01

HQ SPCLT PHARMA

ESMOLOL HYDROCHLORIDE

DCAT Week

Not Confirmed

HQ SPCLT PHARMA

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-15

ESMOLOL HYDROCHLORIDE

US Patent Number : 8829054

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205703

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-15

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

HQ SPCLT PHARMA

ESMOLOL HYDROCHLORIDE

Battery Seminar

Not Confirmed

HQ SPCLT PHARMA

U.S.A

Battery Seminar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-15

ESMOLOL HYDROCHLORIDE

US Patent Number : 8835505

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205703

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-15

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

HQ SPCLT PHARMA

ESMOLOL HYDROCHLORIDE

Battery Seminar

Not Confirmed

HQ SPCLT PHARMA

U.S.A

Battery Seminar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-15

ESMOLOL HYDROCHLORIDE

US Patent Number : 8835505

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205703

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-15

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

HQ SPCLT PHARMA

ESMOLOL HYDROCHLORIDE

Battery Seminar

Not Confirmed

HQ SPCLT PHARMA

U.S.A

Battery Seminar

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-15

ESMOLOL HYDROCHLORIDE

US Patent Number : 8829054

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205703

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-15

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!